QIYI, Inc.'s Hold rating is unchanged; there are both positive and negative takeaways from its recent disclosures. Learn more ...
PYRUKYND is the only medicine approved in the UAE for adults with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia NewBridge Pharmaceuticals, a regional specialty company ...